Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Trillium Group

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 8
Average round size
info
The average size of a deal this fund participated in
$4M
Portfolio companies 7
Rounds per year 0.33
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.12
Exits 3
Key employees 1
http://www.trillium-group.com
Pittsford, New York, United States
Stages of investment
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Logistics
  • RFID
  • Hardware
Summary

Trillium Group is the famous VC, which was founded in 1997. The main office of represented VC is situated in the Pittsford. The venture was found in North America in United States.

Among the most successful fund investment fields, there are Biopharma, Medical Device. The fund has specific favorite in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline iCardiac Technologies, OyaGen, Omni-ID Besides, a startup needs to be aged 6-10 years to get the investment from the fund.

The fund is constantly included in less than 2 deals per year. Deals in the range of 5 - 10 millions dollars are the general things for fund. The real fund results show that this VC is 42 percentage points more often commits exit comparing to other companies. The higher amount of exits for fund were in 2017. The top activity for fund was in 2003. Comparing to the other companies, this Trillium Group performs on 9 percentage points more the average number of lead investments.

The overall number of key employees were 1.

The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Trillium Group, startups are often financed by Stonehenge Capital, Cody Gate Ventures, Advantage Capital. The meaningful sponsors for the fund in investment in the same round are YFY Inc., Stonehenge Growth Equity, Stonehenge Growth Capital. In the next rounds fund is usually obtained by YFY Inc., Stonehenge Growth Equity, Norwest Venture Partners.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Trillium Group:
1 Advantage Capital
2 Cody Gate Ventures
3 Stonehenge Capital
Typical Co-investors
Trillium Group is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Trillium Group:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
1 Kohlberg Kravis Roberts
2 Meritech Capital Partners
3 Microsoft
4 NGP Capital
Funds with the same geo focus
Funds with similar geography of portfolio companies:
1 HBM Healthcare Investments AG
2 IVP (Institutional Venture Partners)
3 JMI Equity
4 Nyca Partners
5 Spectrum Equity
Funds doing lead investments
Funds with similar focus acting as lead investors:
1 Crystal Amber
2 Dallas Capital Management
3 eXome Capital
4 Financial Partners Fund
Look at other 50 related and similar funds Collapse list ↓
Fund NameLocation
ABC Television Australia, New South Wales, Sydney
AgriTech Investment Fund -
Bitmain Beijing, Beijing, China
Crystal Tech Fund Arlington, United States, Virginia
Danka Capital Community of Madrid, Madrid, Spain
Fuyu Ziben China, Shanghai
GlobalBrain Canterbury, Christchurch, New Zealand
Hennepin Healthcare Minneapolis, Minnesota, United States
International Coach Federation Kentucky, Lexington, United States
Kairos Partners Michigan, Milan, United States
New Hill Management England, London, United Kingdom
Peabody Energy Missouri, St Louis, United States
RTM Consulting Cincinnati, Ohio, United States
SOFTBANK Latin America Ventures Florida, Miami, United States
Technopark Luzern -
Terawatt Ventures Cambridge, Massachusetts, United States
Weaving Invest fund -
Wideblue Glasgow, Glasgow City, United Kingdom
Team
Kevin Phelps Partner

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

OyaGen

Biotechnology
Genetics
Health Care
$3M24 Sep 2010
Trillium Group
 Rochester, New York, United States

Analytics
Asset Management
Financial Services
Software
$1M10 Nov 2009
Trillium Group
 New York, United States

iCardiac Technologies

Biopharma
Biotechnology
Health Care
Life Science
14 Nov 2007
Trillium Group
Advantage Capital
Stonehenge Growth Capital
 Rochester, New York, United States

VirtualScopics

Biotechnology
Medical Device
Pharmaceutical
$3M10 Feb 2003
Trillium Group
 Rochester, New York, United States
By posting comments on our website you confirm and acknowledge that:

1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.

2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.

3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.

4. We can moderate comments at any time.

5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.

6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.

Agree

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Trillium Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 8
Average round size 4M
Rounds per year 0.33
Peak activity year 2003
Lead investments 4
Follow on index 0.12
Exits 3
Group Appearance index 0.38

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

OyaGen

Biotechnology
Genetics
Health Care
$3M24 Sep 2010
Trillium Group
 Rochester, New York, United States

Analytics
Asset Management
Financial Services
Software
$1M10 Nov 2009
Trillium Group
 New York, United States

iCardiac Technologies

Biopharma
Biotechnology
Health Care
Life Science
14 Nov 2007
Trillium Group
Advantage Capital
Stonehenge Growth Capital
 Rochester, New York, United States

VirtualScopics

Biotechnology
Medical Device
Pharmaceutical
$3M10 Feb 2003
Trillium Group
 Rochester, New York, United States
Crunchbase icon

Content report

The following text will be sent to our editors:

Send